Divi's Laboratories (BOM:532488) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Change In Receivables?

Divi's Laboratories's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Divi's Laboratories's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Divi's Laboratories's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-5,820 Mil. It means Divi's Laboratories's Accounts Receivable increased by ₹5,820 Mil from Mar. 2024 to Mar. 2025 .

Divi's Laboratories's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹27,310 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Divi's Laboratories's Days Sales Outstanding for the three months ended in Mar. 2025 was 96.40.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Divi's Laboratories's liquidation value for the three months ended in Mar. 2025 was ₹54,343 Mil.

Divi's Laboratories Change In Receivables Historical Data

The historical data trend for Divi's Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Change In Receivables Chart

Divi's Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Receivables

Get a 7-Day Free Trial

-2,653.10

-7,416.20

6,500.00

-3,610.00

-5,820.00

Divi's Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Divi's Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Divi's Laboratories (BOM:532488) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Divi's Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	27310	/	25850	*	91
=	96.40

2. In Ben Graham's calculation of liquidation value, Divi's Laboratories's accounts receivable are only considered to be worth 75% of book value:

Divi's Laboratories's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	37310	-	19630	+	0.75 * 27310	+	0.5 * 32360
=	54,343

Divi's Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (BOM:532488) » Definitions » Change In Receivables

Traded in Other Exchanges

DIVISLAB:India

Address

Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines